In our study, KLK6-high CRC cases in TCGA revealed that 25% of patients in this group had an advanced clinical stage (Stage IV and IVA), while no patients in the KLK6-low group were diagnosed with Stage IV of the disease. The gene discussed is KLK6; the disease is colorectal carcinoma.